Company Filing History:
Years Active: 1988
Title: Katsumi Sugiyama: Innovator in Histamine Release Inhibition
Introduction
Katsumi Sugiyama is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of pharmacology, particularly in the area of histamine release inhibition. His innovative work has the potential to impact various medical treatments and improve patient outcomes.
Latest Patents
Katsumi Sugiyama holds a patent for a method aimed at inhibiting the release of histamine. This invention involves the use of sanguinarine, a benzophenanthridine alkaloid, to inhibit histamine release from mammalian mast cells. This breakthrough could lead to advancements in allergy treatments and other related medical applications. He has 1 patent to his name.
Career Highlights
Sugiyama is currently associated with Vipont Laboratories, where he continues to explore innovative solutions in the pharmaceutical industry. His work at the company reflects his commitment to advancing medical science and improving therapeutic options for patients.
Collaborations
He collaborates with Seizaburo Sakamoto, a fellow researcher, to further enhance the impact of their work in the field. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Katsumi Sugiyama's contributions to the field of histamine release inhibition highlight his role as a key innovator in pharmacology. His work not only showcases his expertise but also holds promise for future medical advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.